Venus Medtech (Hangzhou), Inc. Class H (HK:2500) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Venus Medtech (Hangzhou) Inc. has announced the composition of its board of directors and their roles within the company, highlighting the leadership structure in place. Key figures include Chairman Ting Yuk Anthony Wu and various executive and non-executive directors who will serve on committees such as Audit, Remuneration, and Nomination. This update reflects the company’s governance framework as it continues to navigate the financial markets.
For further insights into HK:2500 stock, check out TipRanks’ Stock Analysis page.